Analyst Reco. NOV Inc.

Equities

NOV

US62955J1034

Market Closed - Nyse Other stock markets 04:00:01 2024-04-25 pm EDT			5-day change	1st Jan Change
18.95 ^USD	+0.64%		+2.43%	-6.56%

12:09am	NOV Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 18	Morgan Stanley Raises Price Target on NOV to $25 From $24 on Removal of 'Saudi Risk Premium,' Keeps Overweight Rating	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Morgan Stanley Raises Price Target on NOV to $25 From $24 on Removal of 'Saudi Risk Premium,' Keeps Overweight Rating	Apr. 18	MT
Piper Sandler Adjusts NOV's Price Target to $22 From $25, Keeps Neutral Rating	Feb. 20	MT
Raymond James Adjusts Price Target on NOV to $25 From $28, Maintains Outperform Rating	Feb. 05	MT
TD Cowen Adjusts Price Target on NOV to $29 From $28, Maintains Outperform Rating	Dec. 12	MT
JPMorgan Upgrades NOV to Overweight From Neutral, Price Target at $25	Dec. 08	MT
Goldman Sachs Raises Price Target on NOV to $19 From $18, Maintains Sell Rating	Nov. 14	MT
Raymond James Adjusts Price Target on NOV to $29 From $28, Maintains Outperform Rating	23-10-30	MT
RBC Lifts Price Target on NOV Inc. to $24 From $23, Keeps Sector Perform Rating	23-10-30	MT
Morgan Stanley Raises Price Target on NOV to $25 From $24, Keeps Overweight Rating	23-10-17	MT
BofA Securities Adjusts Price Target on NOV to $24 From $21, Maintains Buy Rating	23-10-16	MT
Goldman Sachs Adjusts Price Target on NOV to $18 From $16, Maintains Sell Rating	23-08-09	MT
Piper Sandler Adjusts Price Target on NOV to $20 From $22, Maintains Neutral Rating	23-07-31	MT
JPMorgan Raises Price Target on NOV to $22 From $20, Maintains Neutral Rating	23-07-31	MT
Morgan Stanley Adjusts Price Target on NOV to $24 From $22, Maintains Overweight Rating	23-07-31	MT
Citigroup Adjusts NOV's Price Target to $26 From $21, Keeps Buy Rating	23-07-31	MT
Raymond James Adjusts Price Target on NOV to $28 From $27, Maintains Outperform Rating	23-07-31	MT
RBC Lifts Price Target on NOV to $23 From $22, Keeps Sector Perform Rating	23-07-28	MT
Citigroup Trims NOV's Price Target to $21 From $22, Keeps Buy Rating	23-07-18	MT
Capital One Reinstates NOV With Equalweight Rating, $20 Price Target	23-07-14	MT
Raymond James Adjusts Price Target on NOV to $27 From $29, Maintains Outperform Rating	23-07-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. NOV Inc.

Equities

NOV

US62955J1034

Analyst Reco.

Filters